This study was conducted in compliance with the protocol and in accordance with Good Clinical Practices, Medicines, and Healthcare Products Regulatory Agency regulations, and all applicable local and state regulations. The electronic informed consent (eIC) was made available to participants through the study app. Participants signed the eIC electronically and the date was added automatically. Signature of the eIC was required and obtained from all participants before any study-related activities. The eIC was reviewed by West Midlands, Edgbaston, Research Ethics Committee, Manchester, UK. IRAS project ID 1006069, REC:22/WM/0177. Approved by West Midlands – Edgbaston Research Ethics Committee 25 October 2022.